Literature DB >> 9721847

Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis.

M E Smulson1, D Pang, M Jung, A Dimtchev, S Chasovskikh, A Spoonde, C Simbulan-Rosenthal, D Rosenthal, A Yakovlev, A Dritschilo.   

Abstract

During apoptosis, DNA undergoes fragmentation and caspase-3 cleaves poly(ADP-ribose) polymerase (PARP) into both a 24-kDa fragment containing the DNA binding domain and an 89-kDa fragment containing the catalytic and automodification domains. Atomic force microscopy revealed that recombinant full-length PARP bound to plasmid DNA fragments and linked them into chainlike structures. Automodification of PARP in the presence of NAD+ resulted in its dissociation from the DNA fragments, which, nevertheless, remained physically aligned. A recombinant 28-kDa fragment of PARP containing the DNA binding domain but lacking the automodification domain irreversibly bound to and linked DNA fragments in the absence or presence of NAD+. Identical results were obtained on incubation of internucleosomal DNA fragments from apoptotic cells with the products of cleavage of recombinant PARP by purified caspase-3. The 24-kDa product of PARP cleavage by caspase-3 may contribute to the irreversibility of apoptosis by blocking the access of DNA repair enzymes to DNA strand breaks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721847

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.

Authors:  F J Oliver; J Menissier-de Murcia; G de Murcia
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  BID is a critical factor controlling cell viability regulated by IFN-α.

Authors:  Takaya Tsuno; Josef Mejido; Tongmao Zhao; Terry Phillips; Timothy G Myers; Joseph Bekisz; Kathryn C Zoon
Journal:  J Immunother       Date:  2012-01       Impact factor: 4.456

3.  Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.

Authors:  L Liu; W Li; Z Li; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 4.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

5.  Safety control for apoptotic irreversibility.

Authors:  Marie Dutreix
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-24       Impact factor: 11.205

6.  Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling.

Authors:  Paola Castri; Yang-Ja Lee; Todd Ponzio; Dragan Maric; Maria Spatz; Joliet Bembry; John Hallenbeck
Journal:  Biochim Biophys Acta       Date:  2014-03

7.  DNA excision repair and DNA damage-induced apoptosis are linked to Poly(ADP-ribosyl)ation but have different requirements for p53.

Authors:  R Beneke; C Geisen; B Zevnik; T Bauch; W U Müller; J H Küpper; T Möröy
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R B Luo; R Samara; M Jung; A Dritschilo; A Spoonde; M E Smulson
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

9.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  The cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 5'-diphosphate-ribose) polymerase-1.

Authors:  Pengcheng Zhu; Denis Martinvalet; Dipanjan Chowdhury; Dong Zhang; Ann Schlesinger; Judy Lieberman
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.